Gilead Sciences, Inc. (GILD)

Gilead Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6,437	7,564	9,991	6,085	5,412	5,338
Short-Term Investments	1,515	2,049	1,577	2,265	1,446	2,067
Cash & Short-Term Investments	7,952	9,613	11,568	8,350	6,858	7,405
Cash Growth	-6.34%	-16.90%	38.54%	21.76%	-7.39%	-16.08%
Accounts Receivable	5,007	4,913	4,420	4,660	4,777	4,493
Receivables	5,007	4,913	4,420	4,660	4,777	4,493
Inventory	1,896	1,774	1,710	1,787	1,507	1,618
Prepaid Expenses	1,638	899	480	559	1,241	1,181
Other Current Assets	60	1,143	995	729	60	75
Total Current Assets	16,553	18,342	19,173	16,085	14,443	14,772
Property, Plant & Equipment	5,945	6,138	5,929	5,898	5,980	5,663
Long-Term Investments	734	3,753	713	1,819	2,611	2,844
Goodwill	8,314	8,314	8,314	8,314	8,314	8,332
Other Intangible Assets	13,424	16,978	19,948	26,454	28,894	33,455
Long-Term Deferred Tax Assets	2,270	1,964	2,378	-	-	-
Other Long-Term Assets	4,168	3,534	2,540	3,555	2,929	2,886
Total Assets	51,408	59,023	58,995	62,125	63,171	67,952

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	934	715	833	550	905	705
Accrued Expenses	4,624	5,635	5,120	5,003	4,497	6,996
Current Portion of Long-Term Debt	2,416	2,807	1,815	1,798	2,273	1,516
Current Portion of Leases	-	102	113	125	111	101
Current Income Taxes Payable	-	92	1,646	1,208	959	539
Other Current Liabilities	4,028	2,462	2,477	2,596	2,492	1,753
Total Current Liabilities	12,002	11,813	12,004	11,280	11,237	11,610
Long-Term Debt	23,815	22,129	24,896	23,189	22,957	25,179
Long-Term Leases	-	503	498	546	467	489
Long-Term Deferred Tax Liabilities	318	402	724	1,588	2,673	4,356
Other Long-Term Liabilities	2,317	1,558	1,627	2,773	4,628	5,254
Total Liabilities	38,452	36,405	39,749	39,376	41,962	46,888

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1	1	1	1	1	1
Additional Paid-In Capital	9,841	8,932	7,700	6,500	5,550	4,661
Retained Earnings	3,107	13,730	11,497	16,304	15,687	16,324
Comprehensive Income & Other	91	39	132	28	2	83
Total Common Equity	13,040	22,702	19,330	22,833	21,240	21,069
Minority Interest	-84	-84	-84	-84	-31	-5
Shareholders' Equity	12,956	22,618	19,246	22,749	21,209	21,064
Total Liabilities & Equity	51,408	59,023	58,995	62,125	63,171	67,952

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	26,231	25,541	27,322	25,658	25,808	27,285
Net Cash (Debt)	-18,279	-12,954	-15,754	-16,145	-17,705	-18,571
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-14.72	-10.32	-12.55	-12.83	-14.03	-14.72
Filing Date Shares Outstanding	1,240	1,241	1,245	1,246	1,247	1,254
Total Common Shares Outstanding	1,241	1,241	1,246	1,246	1,247	1,254
Working Capital	4,551	6,529	7,169	4,805	3,206	3,162
Book Value Per Share	10.51	18.29	15.51	18.33	17.03	16.80
Tangible Book Value	-8,698	-2,590	-8,932	-11,935	-15,968	-20,718
Tangible Book Value Per Share	-7.01	-2.09	-7.17	-9.58	-12.81	-16.52
Land	-	561	561	561	562	404
Buildings	-	4,623	4,541	4,328	4,390	3,794
Machinery	-	1,241	1,192	2,216	1,990	1,759
Construction In Progress	-	745	501	661	719	1,057

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error